SYNCOPE
Is vasovagal syncope a disease?
1 Division of Cardiology and Arrhythmologic Center, Ospedale Civile, Via Vicini 2, 44042 Cento (FE), Italy; 2 Department of Cardiology and Arrhythmologic Center, Ospedali del Tigullio, Lavagna, Italy; 3 Section of Endocrinology, Department of Biomedical Sciences and Advanced Therapies, University of Ferrara, Italy
Manuscript submitted 4 May 2006. Accepted after revision 16 November 2006.
* Corresponding author. Tel: +051 6838111; fax: +051 6838471. E-mail address: p.alboni{at}ausl.fe.it
 |
Abstract |
|---|
 Top Abstract IntroductionIsolated VVSVasovagal diseaseConclusionReferences |
|---|
Vavovagal syncope (VVS) is not generally associated with cardiovascular, neurological or other diseases, and, therefore, represents an isolated manifestation. Isolated VVS cannot be regarded as a disease for several reasons: spontaneous syncope occurs in about half of individuals during their lives, and the unidentified neural pathways involved in the vasovagal response are probably present in all healthy humans, with individual differences in susceptibility; VVS is induced during tilt testing in several subjects with no history of syncope; during haemorrhagic shock, the vasovagal reaction can be observed in subjects with no history of syncope; about 20% of astronauts, who are selected on the basis of their great resistance to orthostatic stress, experience syncope or presyncope on landing after a short-duration space flight; to date, no genetic basis of VVS has been demonstrated; subjects with VVS are generally normotensive and, importantly, have normal blood pressure regulation apart from the episodes of syncope; hormonal disorders or a generalized state of autonomic involvement, although frequently investigated, have never been clearly demonstrated. Isolated VVS should be distinguished from those forms that start in old age and which are often associated with cardiovascular or neurological disorders, and other dysautonomic disturbances such as carotid sinus hypersensitivity, post-prandial hypotension, and symptoms of autonomic dysfunction. In these subjects, VVS appears as an expression of a pathological process, i.e. a disease, mainly related to a generalized involvement of the autonomic nervous system, which is not yet well-defined from a nosological point of view.
Key Words: Vasovagal syncope, Syncope, Tilt test
|
Introduction |
|---|
|
TopAbstractIntroductionIsolated VVSVasovagal diseaseConclusionReferences |
|---|
Classical vasovagal syncope (VVS) is mediated by emotional or orthostatic stress and can be diagnosed by history taking.1
It is diagnosed when precipitating events such as fear, severe pain, emotional distress, instrumentation, or prolonged standing are associated with typical prodromal symptoms.1,2 Classical VVS generally starts at a young age, the most commmon age at which it first presents is 13 years,3 and the natural history is extremely variable; some subjects experience only a single episode during their lives, while others have frequent episodes. In the vast majority of subjects, VVS is not associated with cardiovascular, neurological or other diseases, and, therefore, constitutes an isolated manifestation (‘isolated VVS’). Vasovagal syncope is benign and very common; in fact, it was reported in 39% of young medical students (median age 21 years),4 and it is, therefore, more likely that up to 50% of all individuals experience loss of consciousness at some time during their lives. Most of these have only one or few episodes.2,4 Most subjects do not seek medical assistance.1 The pathophysiology of the hypotension/bradycardia reflex responsible for VVS is not completely understood. However, much evidence suggests that hypotension is secondary to transient withdrawal of sympathetic tone and bradycardia is secondary to a transient increase in vagal discharge. |
Isolated VVS |
|---|
|
TopAbstractIntroductionIsolated VVSVasovagal diseaseConclusionReferences |
|---|
We believe that isolated VVS is not a disease for two main reasons:
- Spontaneous syncope occurs in about half of the individuals in their lives, but the unidentified neural pathways involved in the vasovagal response are probably present in all healthy humans, with individual differences in susceptibility. This assertion is supported by some data reported in the literature.
- Head-up tilt testing (HUT) is used to assess individual susceptibility to VVS and the results of most studies suggest that this test discriminates fairly well between adult subjects with syncope and asymptomatic control subjects. However, 10–15% of adult subjects without a history of fainting experience syncope during HUT at 60–70° (false positives). On using a stronger stressor, such as a tilt angle of 80° in conjunction with low-dose isoprenaline, the percentage of asymptomatic adults experiencing vasovagal reaction increases to 40–45%.5,6 Among children, the percentage of asymptomatic subjects developing vasovagal reactions during HUT is also very high, approaching 40% even when a mild stressor is applied.7 It should also be considered that orthostatic stress is only one of the many stressors known to provoke syncope. For example, the addition of instrumentation with an intravenous line during HUT, in both young and elderly subjects with no history of fainting, markedly increases the incidence of vasovagal reaction.8,9 These results suggest that about 50% of all individuals experience spontaneous fainting and about 40% of the other half experience VVS only under intense orthostatic stress. The autonomic reflex, therefore, appears to be predisposed in about 70% of all individuals.
- Haemorrhagic shock can present a situation similar to VVS. The volume loss caused by haemorrhage results in hypotension and a fall in venous return, which can lead to inappropriate sympathetic-inhibition and a subsequent paradoxical response characterized by a further fall in blood pressure, associated with bradycardia. This vasovagal reaction, which is probably secondary to a strong trigger such as a severe reduction in venous return, can be observed in subjects with no history of syncope10 and, therefore, cannot be considered an expression of a pathological disorder.
- Astronauts are selected on the basis of their great resistance to orthostatic and gravitational changes. Despite this selection, however, about 20% experience presyncope, and some experience a frank bradycardiac syncope during upright posture on the day of landing after a short-duration space flight.11 This has been attributed to central control system remodelling, which is a transient dysfunction of central integration of baroreflex afferent input as, during weightlessness, the central nervous system receives no baroceptor input from upright posture.11
The abovementioned considerations suggest that about half of healthy individuals experience spontaneous syncopal episodes during their lives and that many of the others have a susceptibility to VVS that can be unmasked by intense stress. An autonomic reflex which is potentially triggered in the vast majority of individuals cannot be regarded as a pathological disorder.
In addition, it should also be considered that:- To date, a genetic basis of VVS has not been demonstrated, though cases of familial VVS have been reported. A case-control study by Camfield et al.12 showed that, among children with VVS, a significant proportion had a parent or a sibling with syncope, an association not seen in control subjects. Mathias et al.13 reported a familial tendency for VVS, which was confirmed by HUT. They observed a positive family history of VVS in 90% of their group under the age of 20 years. Two sets of monozygotic twins with recurrent syncope have also been reported.14 However, these data do not show that the effect of family history is due to genetic factors; indeed, it remains possible that it is due to sociocultural, psychological, or environmental factors.
- Some authors suggested that spontaneous VVS has not been clearly demonstrated in animals.15 Even if quadrupeds are, very likely, less susceptible to VVS, we believe that some data suggest the possibility of a vasovagal reflex in mammals. In experimental studies carried out in rats, severe reduction in venous return induced reflex bradycardia and hypotension.16 Moreover, in some vertebrates tonic immobility occurs as a fear response in order to simulate death for self-defence. Reports on haemodynamic responses in tonic immobility are scarce, but bradycardia and lowered blood pressure have been demonstrated in some animals, particularly the opossum and some kinds of rabbits.17,18 It is not clear whether the vasovagal reflex is voluntarily induced or not. However an autonomic reflex aimed at self-defence cannot be considered a pathological finding.
- To date, a genetic basis of VVS has not been demonstrated, though cases of familial VVS have been reported. A case-control study by Camfield et al.12
- Head-up tilt testing (HUT) is used to assess individual susceptibility to VVS and the results of most studies suggest that this test discriminates fairly well between adult subjects with syncope and asymptomatic control subjects. However, 10–15% of adult subjects without a history of fainting experience syncope during HUT at 60–70° (false positives). On using a stronger stressor, such as a tilt angle of 80° in conjunction with low-dose isoprenaline, the percentage of asymptomatic adults experiencing vasovagal reaction increases to 40–45%.5
- Typically, subjects with VVS have no evidence of underlying heart or neurological disease. These subjects are generally normotensive and, importantly, have normal blood pressure regulation outside the episodes of syncope. In some studies,19–21 with one exception,22 the behaviour of blood pressure during the first minutes of HUT, before the beginning of the vasovagal reaction, was similar in VVS subjects and in control subjects without a history of fainting. Contrary to the general belief, subjects with VVS do not have an increased vagal tone during everyday life.23 These data suggest that a generalized state of autonomic involvement is not present in these individuals. Admittedly, in some studies subtle alterations have been reported in subjects with VVS during orthostatic stress: impaired venoconstriction,20,24 lower increase in total peripheral resistance,24 higher increase in heart rate,25 and enhanced sympathetic activity26; impaired baroreflex sensitivity26 and reduced blood volume27 have also been described. However, other studies have failed to confirm these subtle alterations21,28–35 and their presence is currently uncertain in subjects with VVS. A multiplicity of mechanisms may contribute to these different observations. In any case, these subtle alterations cannot be regarded as pathological disorders; at worst they are an expression of susceptibility to VVS. Moreover, a cause-effect relationship cannot be established.
Some observations have suggested that the serotoninergic system is impaired in subjects with VVS. The withdrawal of sympathetic outflow leading to hypotension could be mediated by serotonin. Indeed, the administration of intracerebroventricular serotonin induces inhibition of sympathetic nerve activity and hypotension.36 Thus, a sudden surge in central serotonin levels may contribute to the mechanism of sympathetic withdrawal. Theodorakis et al.37 observed that, during HUT, subjects with a typical history of VVS had increased prolactin and cortisol responses after infusion of clomipramine (a serotonergic re-uptake inhibitor) compared with a control group with no history of fainting, and it has been concluded that central serotoninergic mechanisms are involved in the genesis of VVS, on the assumption that this higher hormonal responsiveness to clomipranine could be a consequence of central serotoninergic activation. In a recent study carried out in a larger population,21 the response to orthostatic stress in terms of cortisol and prolactin secretion was similar in subjects with VVS and in a control group with no history of fainting; the authors concluded that the serotoninergic system is not impaired in subjects with VVS. Support for this conclusion has recently been provided by Alboni et al.38 who assessed the serotoninergic system by determining plasma and platelet serotonin levels during HUT in subjects with VVS. They did not observe any significant change in blood levels of serotonin at the beginning of the prodrome, during loss of consciousness and on recovery of consciousness. The inability to document increased serotoninergic system activation may be related to the fact that only peripheral measurements were taken. However, there is evidence indicating a good correlation between central and peripheral serotoninergic activity.39 In a small controlled study40 oral paroxetine, a serotonin receptor antagonist, improved symptoms in subjects with VVS; in another,41 however, oral paxil, another serotonin receptor antagonist, did not prevent the vasovagal reaction during orthostatic stress. To date, an impairment of the serotoninergic system in subjects with VVS has not been clearly demonstrated.
It has been suggested that other hormonal factors such as adrenaline,42 arginine vasopressin,43 beta-endorphins,44 adenosine,45 and galanin46,47 may play a role in eliciting VVS. However, a pathophysiological role of these hormonal factors has not yet been demonstrated.
In conclusion, on the basis of all the above findings, we believe that isolated VVS is not a disease, but rather the clinical manifestation of an autonomic reflex predisposed in all (or almost all) individuals. Why certain subjects appear to be more susceptible than others to the development of paradoxical hypotension and bradycardia, and why the event occurs at one time and not at another, remains unknown. However, this increased susceptibility can lead to trauma, severe anxiety, or depression.
|
Vasovagal disease |
|---|
|
TopAbstractIntroductionIsolated VVSVasovagal diseaseConclusionReferences |
|---|
The considerations reported above refer to classical VVS. However, the classification of the causes of syncope used by the Task Force on syncope of the European Society of Cardiology includes some forms of non-classical vasovagal syncope that are diagnosed on the basis of minor clinical criteria, exclusion of other causes of syncope (absence of heart disease), and positive response to HUT.1
Examples of non-classical VVS include episodes without (or with minimal) triggering events or prodromal symptoms. It is known that clinical manifestations change significantly in older subjects and that medical history has a limited value in establishing the cause of syncope in older people.48 In the EGSYS 2 study,49 the age of onset of VVS in 190 subjects admitted urgently to hospital was 52 ± 23 years (unpublished data). This study involved a population-based sample of consecutive patients referred to emergency departments, a sample which was biased only by access criteria. Their age distribution showed that the age of onset is distributed throughout life, peaking at the age of 20 and after the age of 70 years (Figure 1). In subjects in whom VVS starts in old age, loss of consciousness cannot be regarded as an isolated manifestation, as it is frequently associated not only with cardiovascular or neurological diseases but also with other dysautonomic disturbances, such as carotid sinus hypersensitivity, post-prandial hypotension, progressive orthostatic hypotension, and symptoms of autonomic dysfunction (abnormal sweating, abnormal thermoregulation, etc.).50,51 Even though VVS starting in old age shares the same pathophysiological mechanism of hypotension—bradycardia with isolated VVS both during HUT and during documented spontaneous syncope,50,52 these findings prompt us to regard it as an expression of a pathological process mainly related to a generalized involvement of the autonomic nervous system or, more generally, to the ageing process. Therefore, VVS starting in old age should be considered a disease, or, at least, part of a more complex disease. The clinical features of isolated VVS and of vasovagal disease are summarized in Table 1. Although this subdivision engenders the risk of oversimplification since several intermediate forms are present, we believe it may be useful for practical purposes. Vasovagal syncope starting in old age sometimes progressively worsens over time, and major injuries are frequent,52 mainly when a prodrome is lacking. In this regard, a specific therapy guided by electrocardiographic examination at the time of syncope recurrence has proved effective in relieving recurrences.52 In contrast, no specific therapy is generally warranted in most subjects affected by isolated VVS.
|
|
|
Conclusion |
|---|
|
TopAbstractIntroductionIsolated VVSVasovagal diseaseConclusionReferences |
|---|
In conclusion, we believe that isolated VVS is not a disease, whereas VVS starting in old age appears to be an expression of a disease that has not yet been clearly defined from the nosological point of view.
|
References |
|---|
|
TopAbstractIntroductionIsolated VVSVasovagal diseaseConclusionReferences |
|---|
[1] Brignole M, Alboni P, Benditt DG, Bergfeldt L, Blanc JJ, Block Thomsen PE, et al. Guidelines on management (diagnosis and treatment) of syncope—update 2004. Europace 2004; 6: 467–537.
[2] Alboni P, Brignole M, Menozzi C, Raviele A, Del Rosso A, Dinelli M, et al. Clinical spectrum of neurally mediated reflex syncopes. Europace 2004; 6: 55–62.
[3] Sheldon RS, Sheldon AG, Connolly SJ, Morillo CA, Klingenheben T, Krahn AD, et al. Age of first faint in patients with vasovagal syncope. J Cardiovasc Electrophysiol 2006; 17: 49–54.[CrossRef][Web of Science][Medline]
[4] Ganzeboom KS, Colman N, Reitsma JB, Shen WK, Weiling W. Prevalence and triggers of syncope in medical students. Am J Cardiol 2003; 91: 1006–1008.[CrossRef][Web of Science][Medline]
[5] Kapoor WN and Bront N. Evaluation of syncope by upright tilt test with isoproterenol: a nonspecific test. Ann Intern Med 1992; 116: 358–63.
[6] Natale A, Akhtar M, Jazayeri M, Dhala A, Blanck Z, Deshpande S, et al. Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation 1995; 92: 54–58.
[7] De Jong-de Vos van Steenwijk CCE, Wieling W, Johannes JM, Harms MP, Kuis W, Wesseling KH. Incidence of hemodynamics of near-fainting in healthy 6–16 year old subjects. J Am Coll Cardiol 1995; 25: 1615–21.[Abstract]
[8] Stevens PM. Cardiovascular dynamics during orthostasis and the influence of intravascular instrumentation. Am J Cardiol 1966; 17: 211–18.[CrossRef][Web of Science][Medline]
[9] Mc Intosh SJ, Lawson J, Kenny RA. Intravenous cannulation alters the specificity of head-up tilt testing for vasovagal syncope in elderly patients. Age Ageing 1994; 23: 317–19.
[10] Sander-Jensen K, Secher NH, Bie P, Warberg J, Schwartz TW. Vagal slowing of the heart during haemorrage: observations from 20 consecutive hypotensive patients. BMJ 1986; 292: 364–66.
[11] Meck JV, Waters WW, Ziegler MG, de Block HF, Mills PJ, Robertson D, et al. Mechanisms of postspaceflight orthostatic hypotension: low 
1-adrenergic receptor responses before flight and central autonomic dysregulation postflight and central autonomic dysregulation postflight. Am J Physiol Heart Circ Physiol 2004; 286: H1486–H95.
[12] Camfield PR and Camfield CS. Syncope in childhood: a case control clinical study of the family tendency to faint. Can J Neurol Sci 1990; 17: 306–8.[Web of Science][Medline]
[13] Mathias C, Deguchi K, Bleasdale-Barr K, Kimber J. Frequency of family history in vasovagal syncope. Lancet 1998; 352: 33–4.[Web of Science][Medline]
[14] Marquez MF, Urias KI, Hermosillo AG, Jardon JL, Iturralde P, Colin L, et al. Familial vasovagal syncope. Europace 2005; 7: 472–74.
[15] van Dijk JG. Fainting in animals. Clin Auton Res 2003; 13: 247–55.[CrossRef][Web of Science][Medline]
[16] Waxman MB, Asta JA, Cameron DA. Localization of the reflex pathway responsible for the vasodepressor reaction induced by inferior vena cava occlusion and isoproterenol. Can J Physiol Pharmacol 1992; 70: 882–89.[Web of Science][Medline]
[17] Carli G. Blood pressure and heart rate in the rabbit during animal hypnosis. Electroenceph Clin Neurophysiol 1974; 37: 231–7.[CrossRef][Web of Science][Medline]
[18] Gabrielsen GW and Smith EN. Physiological responses associated with feigned death in the American opossum. Acta Physiol Scand 1985; 123: 393–8.[Web of Science][Medline]
[19] CoShen WK, Low PA, Rea RF, Lohse CM, Hodge DD, Hammil SC. Distinct hemodynamic profiles in patients with vasovagal syncope: a heterogeneous population. J Am Coll Cardiol 2000; 35: 1470–7.
[20] Steward JM, McLeod KJ, Sanyal S, Herzberg G, Montgomery LD. Relation of postural vasovagal syncope to splanchnic hypervolemia in adolescents. Circulation 2004; 110: 2575–81.
[21] Guzman JC, Garcia RG, Dillenburg R, Sieger FS, Lopez-Jaramillo P, Morillo CA. Central serotoninergic response to orthostatic challenge in patients with neurocardiogenic syncope. Europace 2006; 8: 306–11.
[22] Nwosu EA, Rahko PS, Hanson P, Grogan EW. Hemodynamic and volumetric response of the normal left ventricle to upright tilt testing. Am Heart J 1994; 128: 106–13.[CrossRef][Web of Science][Medline]
[23] Van Den Berg MP and Smit AJ. Bedside autonomic function testing in patients with vasovagal syncope. Pacing Clin Electrophysiol 1997; 20: 2039–42.[CrossRef][Medline]
[24] Thomson HL, Atherton JJ, Khafagi FA, Frenneaux MP. Failure of reflex venocostriction during exercise in patients with vasovagal syncope. Circulation 1996; 93: 953–59.
[25] Furlan P, Piazza S, Dell'Orto S, Barbie F, Blanchi A, Mainardi L, et al. Cardiac autonomic patterns preceding occasional vasovagal reactions in healthy humans. Circulation 1998; 98: 1756–61.
[26] Bechir M, Binggeli C, Corti R, Chenevard R, Spieker L, Ruschitzka F, et al. Dysfunctional baroflex regulation of sympathetic nerve activity in patients with vasovagal syncope. Circulation 2003; 107: 1620–25.
[27] Bergenwald L, Freyschuss V, Sjöstrand T. The mechanism of orthostatic and hemorragic fainting. Scand J Clin Lab Invest 1977; 37: 209–16.[Web of Science][Medline]
[28] Epstein SE, Stampfer M, Beiser GD. Role of capacitance and resistance vessels in vasovagal syncope. Circulation 1968; 37: 524–33.
[29] Jaeger FJ, Malonely JD, Castle LW, Fonad-Tarazi FM. Is absolute hypovolemia a risk factor for vasovagal response to head-up tilt? Pacing Clin Electrophysiol 1993; 16: 743–50.[CrossRef][Medline]
[30] Sneddon JF, Counihan PJ, Bashir Y, Haywood GA, Ward DE, Camm AJ. Assessment of autonomic function in patients with neurally mediated syncope. Augmented cardiopulmonary baroceptor responses to graded orthostatic stress. J Am Coll Cardiol 1993; 21: 1193–98.[Abstract]
[31] Novak V, Honos G, Shondorf R. Is the heart empty at syncope? J Auton Nerv Syst 1996; 60: 83–92.[CrossRef][Web of Science][Medline]
[32] Morillo CA, Eckberg DL, Ellenbogen KA, Beightol LA, Hoag JB, Tahvanainen KU, et al. Vagal and symptathetic mechanisms in patients with orthostatic vasovagal syncope. Circulation 1997; 96: 2509–13.
[33] Morillo CA, Klein GJ, Jones DL, Yee R. Time and frequency domain analyses of heart rate variability during orthostatic stress in patients with neurally mediated syncope. Am J Cardiol 1994; 74: 1258–62.[CrossRef][Web of Science][Medline]
[34] Mosqueda-Garcia R, Furlan R, Fernandez-Violante R, Desai T, Snell M, Jarai Z, et al. Sympathetic and baroreceptor reflex function in neurally mediated syncope evoked by tilt. J Clin Invest 1997; 99: 2736–44.[Web of Science][Medline]
[35] Thomson HL, Wright K, Frenneaux M. Baroflex sensitivity in patients with vasovagal syncope. Circulation 1997; 95: 395–400.
[36] Abboud F. Neurocardiogenic syncope. N Engl J Med 1993; 328: 1117–20.
[37] Theodorakis GN, Markianos M, Zarvalis E, Livanis EG, Flevari P, Kremastinos DT. Provocation of neurocardiogenic syncope by clomipramine administration during the head-up tilt test in vasovagal syndrome. J Am Coll Cardiol 2000; 36: 174–8.
[38] Alboni P, Bondanelli M, Dinelli M, Gruppillo P, Franceschetti P, Marchi P, et al. Role of the serotonergic system in the genesis of vasovagal syncope. Europace 2000; 2: 172–80.
[39] Houston DS and Vanhoutte PM. Serotonin end the vascular system. Role in health and disease, implications for therapy. Drugs 1986; 31: 149–63.[Web of Science][Medline]
[40] Di Girolamo E, Di Iorio C, Sabatini P, Leonzio L, Barbone C, Barsotti A. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 33: 1227–30.
[41] Takata TS, Wasmund SL, Smith ML, Li JM, Joglar JA, Banks KA, et al. Serotonin reuptake inhibitor (Paxil) does not prevent the vasovagal reaction associated with carotid sinus massage and/or lower body negative pressure in healthy volunteers. Circulation 2002; 106: 1500–4.
[42] Benditt DG, Ermis C, Padanilau B, Samniah N, Sakaguchi S. Catecholamine response during haemodynamically stable upright posture in individuals with and without tilt-table induced vasovagal syncope. Europace 2003; 5: 65–70.
[43] Fitzpatrick A, Williams T, Ahmed R, Lightman S, Bloom SR, Sutton R. Echocardiographic and endocrine changes during vasovagal syncope induced by prolonged head-up tilt. Eur J Card Pacing Electrophysiol 1992; 2: 121–8.
[44] Wallbridge DR, MacIntyre HE, Gray CE, Denvir MA, Oldroyd KG, Rae AP, et al. Increase in plasma ß endorphins precedes vasodepressor syncope. Br Heart J 1994; 71: 446–8.
[45] Shen WK, Hammill SC, Munger TM, Stanton MS, Packer DL, Osborn MJ, et al. Adenosine: potential modulator for vasovagal syncope. J Am Coll Cardiol 1996; 28: 146–54.[Abstract]
[46] Bondanelli M, Alboni P, Margutti A, Franceschetti P, Dinelli M, Gruppillo P, et al. Plasma galanin response to head-up tilt in normal subjects and patients with recurrent vasovagal syncope. Metabolism 2003; 52: 315–21.[CrossRef][Web of Science][Medline]
[47] Hinghofer-Szalkay HG, Rössler A, Evans JM, Stenger MB, Moore FB, Knapp CF. Circulatory galanin levels increase severalfold with intense othostatic challenge in healthy humans. J Appl Physiol 2006; 100: 844–9.
[48] Del Rosso A, Alboni P, Brignole M, Menozzi C, Raviele A. Relation of clinical presentation of syncope to the age of patients. Am J Cardiol 2005; 96: 1431–1435.[CrossRef][Web of Science][Medline]
[49] Brignole M, Menozzi C, Bartoletti A, Giada F, Lagi A, Ungar A, et al. A new management of syncope. Prospective systematic guideline-based evaluation of patients referred urgently to general hospitals. Eur Heart J 2006; 27: 76–82.
[50] Brignole M, Menozzi C, Gianfranchi L, Oddone D, Lolli G, Bertulla A. Carotid sinus massage, eyeball compression and head-up tilt test in patients with syncope of uncertain origin and in healthy control subjects. Am Heart J 1991; 122: 1644–51.[CrossRef][Web of Science][Medline]
[51] McIntosh SJ, Lawson J, Kenny RA. Clinical characteristics of vasodepressor, cardioinhibitory and mixed caortid sinus syndrome in the elderly. Am J Med 1993; 95: 203–8.[CrossRef][Web of Science][Medline]
[52] Brignole M, Sutton R, Menozzi C, Garcia-Civera R, Moya A, Wieling W, et al. Early application of an implantable loop recorder allows effective specific therapy in patients with recurrent suspected neurally mediated syncope. Eur Heart J 2006; 27: 1085–92.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J.-J. Blanc To avoid fainting: cross the legs and not the fingers Europace, January 26, 2010; (2010): euq004v1 - euq004. [Full Text] [PDF]
|
|
|
|
|
|
G. Fuca, M. Dinelli, L. Gianfranchi, S. Bressan, C. Lamborghini, and P. Alboni Do subjects with vasovagal syncope have subtle haemodynamic alterations during orthostatic stress? Europace, June 1, 2008; 10(6): 751 - 759. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Tan and S. W. Parry Vasovagal syncope in the older patient. J. Am. Coll. Cardiol., February 12, 2008; 51(6): 599 - 606. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||